Consumer Durables & Banking Stocks Trade Lower

Fri, 29 Jul 01:30 pm

   Previous Close   

   Pre-Open   

   09:30 am   

   11:30 am   

   Closing   

Indian indices continue to languish in the negative territory during the post-noon trading session. Sectoral indices are trading on a mixed note with stocks from the healthcare, oil & gas sectors leading the gains. consumer durables and banking stocks are however trading in the red.

The BSE Sensex is trading lower by 94 points (down 0.3%) and the NSE Nifty is trading lower 18 points (down 0.2%). The BSE Mid Cap index is trading up 0.9% while the BSE Small Cap index is trading up by 0.7%. Gold prices, per 10 grams, are trading at Rs 31,071 levels. Silver price, per kilogram is trading at Rs 47,235 levels. Crude oil is trading at Rs 2,757 per barrel. The rupee is trading at 67.05 to the US$.

As per an article in The Economic Times, Axis Bank and Life Insurance Corporation of India (LIC) has signed a Memorandum of Understanding to distribute LIC's multiple life insurance products to their customers.

Reportedly, this is the largest bancassurance partnership after the insurance regulator allowed banks to sell policies of more than one company.

In the initial phase, the bank will distribute LIC's life insurance products across its branches in West Bengal, Bangalore and Haryana. Additionally, it will also provide post sales services, reports stated.

Apart from LIC, Axis Bank also has a tie-up with Max Life Insurance in the life insurance space.

LIC holds a 77% market share in policies and 70% share in first premium, while Axis Bank has a network of over 3,000 branches all over. Whether this synergy of the two behemoths help them enhance customer satisfaction and expand its offerings would be a key thing to watch out for going forward.

Shares of Axis Bank were trading up by 0.5% while writing.

Moving on to the news from pharma sector. According to an article in a leading financial daily, <>Ajanta Pharma Limited announced the receipt of final approval for Omeprazole and Sodium Bicarbonate Powder for Oral Suspension from US FDA (Food and Drug Administration) (Subscription Required).

It is a bioequivalent generic version of Zegerid Powder used in the treatment of acid reflux and ulcers. The company will be launching this product soon in 2 variants 20 mg / 1680 mg and 40 mg / 1680 mg powder sachets.

In total, the company has 26 abbreviated new drug application (ANDA) of which it has final approvals for 12 ANDAs, 1 tentative approval and 13 ANDAs are under review with USFDA, the reports stated.

Speaking about the pharma's regulatory distresses, are Indian pharma companies now adapting to the scrutiny by the USFDA? Madhu Gupta, Managing Editor of ResearchPro, shares her insights in one of our premium editions of The 5 Minute Wrap Up (Subscription Required).

Ajanta Pharma was trading up by 2.3% at the time of writing.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary

Top Gainers TodayTop Gainers over 1-WeekTop Gainers over 1-MonthTop Gainers over 1-YearTop Gainers over 3-YrsTop Gainers over 5-YrsTop Losers TodayTop Losers over 1-WeekTop Losers over 1-MonthTop Losers over 1-YearTop Losers over 3-YrsTop Losers over 5-YrsOnly BuyersOnly SellersMost Active StocksMost Popular Stocks52 Week High Stocks52 Week Low Stocks

INDICESBSE (Rs 0 to 1)BSE (Rs 1 to 2)BSE (Rs 2 to 4)BSE (Rs 4 to 10)BSE (Rs 10 to 20)BSE (Above Rs 20)BSE - AllBSE-30BSE-100BSE-200BSE-500BSE AutoBSE BankexBSE Capital GoodsBSE Consumer DurablesBSE FMCGBSE HealthcareBSE ITBSE MetalBSE Oil & GasBSE PSUBSE TeckBSE RealtyBSE PowerBSE A GroupBSE B GroupBSE Mid-CapBSE Small-CapBSE Basic MaterialsBSE Consumer DiscretionaryBSE IndustrialsBSE UtilitiesBSE Sensex 50BSE Sensex Next 50BSE Bharat 22BSE 150 MidCapBSE 250 SmallCapBSE 250 LargeMidCapBSE 400 MidSmallCapBSE AllCapBSE LargeCapBSE SmallCap SelectBSE 100 LargeCap TMCBSE InfraBSE ManufacturingBSE CPSEBSE Private BankBSE Diversified FinancialsBSE MomentumBSE Low VolatilityBSE QualityBSE Enhanced ValueBSE Divident StabilityS&P BSE IPOBSE SMEIPOBSE 100 ESGBSE CarbonexBSE GreenexNSE (Rs 0 to 10)NSE (Rs 10 to 20)NSE (Above Rs 20)NSE - AllNSE-50NSE ITNSE Nifty Midcap 50NSE JR. NiftyNSE Bank NiftyNIFTY Next 50NIFTY 100NIFTY 200NIFTY 500NIFTY MidCap 100NIFTY SmallCap 250NIFTY SmallCap 50NIFTY SmallCap 100NIFTY LargeMidCap 250NIFTY MidSmallCap 400NIFTY AutoNIFTY Consumer DurablesNIFTY FinanceNIFTY FMCGNIFTY MediaNIFTY MetalNIFTY PharmaNIFTY Private BankNIFTY PSU BankNIFTY RealtyNIFTY Oil & GasNIFTY SME EmergeNIFTY CommoditiesNIFTY CPSENIFTY EnergyNIFTY India ConsumptionNIFTY InfraNIFTY MNCNIFTY PSENIFTY Serv SectorNIFTY100 Liquid 15NIFTY Midcap Liquid 15NIFTY Midcap 150 Quality 50NIFTY50 Equal WeightNIFTY100 Equal WeightNIFTY100 Low Volatility 30NIFTY100 Alpha 30NIFTY Alpha 50NIFTY Dividend Opportunities 50NIFTY High Beta 50NIFTY Low Volatility 50NIFTY200 Quality 30NIFTY 500 Value 50NIFTY 100 Quality 30SECTORSAgricultureAirlinesAluminiumAsset Management CompaniesAutomobilesAuto AncillariesBanks (Private)Banks (PSU)BankingCementChemicalsDefenceDiagnosticsDronesEngineeringElectric VehicleElectric Vehicle BatteryEnergy SourcesESGEthanolFertilizersFintechFMCGFoodGreen HydrogenHotelsInfrastructureInsuranceInvestment and FinanceInvITIT (Large)IT (Others)LogisticsMediaMetalMiningIndia's Big Tech StocksIndian PharmaMNC PharmaPSUPaintPaperPlasticPowerRating AgenciesReal EstateREITsRenewable EnergyRetailingSemiconductorShippingSteelSugarSupply ChainTelecomTextilesTravel Support Services

10 results 25 results 50 results 100 results All results

Indian Share Market Update: Top Gainers and Losers